Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong · Delayed Price · Currency is HKD 0.7350
-0.0250 (-3.29%)
Oct 9, 2026, 3:59 PM HKT
HKG:3737 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,647 | 1,737 | 2,215 | 2,050 | 1,826 | 1,747 |
Revenue Growth | -5.21% | -21.55% | 8.05% | 12.26% | 4.55% | 8.89% |
Gross Profit Gross Profit Growth | 875.92 | 940.25 | 1,281 | 1,215 | 1,067 | 1,061 |
Operating Income Operating Income Growth | 13.66 | -1.67 | 125.14 | 164.4 | 103.51 | 79.58 |
Net Income Net Income Growth | 17.62 | 17.29 | 95.21 | 162.78 | 106.39 | 52.13 |
Earnings Per Share EPS Growth | 0.02 | 0.02 | 0.11 | 0.19 | 0.13 | 0.06 |
EPS Growth | 5.13% | -81.82% | -42.11% | 51.27% | 109.34% | -64.10% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | -529.97 | -592.07 | -708.24 | -696.22 | -717.95 | -823.96 |
Operation of Chain Pharmacies Operation of Chain Pharmacies Growth | 512.11 | 528.81 | 590.49 | 634.15 | 696.03 | 693.22 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 1,665 | 1,801 | 2,333 | 2,112 | 1,848 | 1,877 |
Total Total Growth | 1,647 | 1,737 | 2,215 | 2,050 | 1,826 | 1,747 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 185.38 | 198.92 | 199.69 | 192.3 | 419.36 | 257.85 |
Total Debt Total Debt Growth | 87.63 | 130.01 | 188.6 | 174.86 | 170.86 | 175.74 |
Net Cash (Debt) Net Cash Growth | 97.75 | 68.91 | 11.09 | 17.45 | 248.5 | 82.1 |
Net Cash Growth | 41.86% | 521.45% | -36.45% | -92.98% | 202.67% | -33.32% |
Net Cash Per Share Net Cash Per Share Growth | 0.12 | 0.08 | 0.01 | 0.02 | 0.29 | 0.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 168.89 | 179.7 | 181.48 | 101.5 | 284.57 | 178.38 |
Capital Expenditures CapEx Growth | -30.82 | -35.22 | -140.76 | -169.18 | -88.41 | -185.85 |
Free Cash Flow Free Cash Flow Growth | 138.07 | 144.47 | 40.72 | -67.68 | 196.17 | -7.47 |
Free Cash Flow Growth | -4.43% | 254.76% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.18% | 54.12% | 57.85% | 59.25% | 58.45% | 60.77% |
Operating Margin | 0.83% | -0.10% | 5.65% | 8.02% | 5.67% | 4.56% |
Pretax Margin | 1.94% | 1.09% | 6.63% | 10.13% | 7.16% | 3.54% |
Profit Margin | 1.07% | 1.00% | 4.30% | 7.94% | 5.83% | 2.99% |
FCF Margin | 8.38% | 8.31% | 1.84% | -3.30% | 10.74% | -0.43% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.047 | 0.082 | 0.053 |
Dividend Per Share Growth | -42.49% | 53.92% | - |
Dividend Yield | 5.35% | 6.90% | 6.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.28 | 25.14 | 8.44 | 6.84 | 7.83 | 13.36 |
Forward PE | - | 10.30 | 10.30 | 10.30 | 10.30 | 10.30 |
P/FCF Ratio | 3.98 | 3.01 | 19.73 | - | 4.25 | - |
PS Ratio | 0.33 | 0.25 | 0.36 | 0.54 | 0.46 | 0.40 |